Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyPresbyterian Lynch Testing Prior Auth | OpenPayer
    Ask Trek AI about this page
    CurrentPresbyterian Health PlanPolicy 7.5

    Genetic Testing for Lynch Syndrome

    Customize your policy alerts

    Sign up for Presbyterian Health Plan Policy 7.5 alerts

    Get alerted when Policy 7.5 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and prior authorization for genetic and molecular testing used to evaluate Lynch syndrome for Presbyterian Health Plan commercial, Medicaid managed, and Medicare Advantage members. Coverage follows the most recent NCCN guideline and remains subject to the member’s specific benefit plan and Schedule of Benefits.

    Policy Summary
    PayerPresbyterian Health Plan
    PolicyGenetic Testing for Lynch Syndrome
    Policy CodePolicy 7.5
    Change TypePolicy update
    Effective DateApr 18, 2024
    Last ReviewNov 19, 2025
    Next Review DateNot specified
    Key ActionPrior authorization is required; submit the request through Pres Online.
    SourceLink
    POLICY UPDATE CHANGES

    Code 0130U was added to the policy and is listed among the codes requiring prior authorization.

    Code 81436 was removed because it was deleted effective 01/01/2025.

    RequiredPrior authorization for applicable Lynch syndrome testing
    18

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Codes requiring prior authorization
    4Gene-specific Lynch syndrome categories
    5Core Lynch syndrome genes

    NCCN-Based Coverage Criteria

    NCCN-Based Coverage Criteria

    Coverage follows the most recent NCCN guideline for Lynch syndrome.

    NCCN-based coverage: Requested genetic or molecular testing must be evaluated using the most recent NCCN Guideline for Genetic/Familial High-Risk Assessment: Colorectal, including the applicable Detection, Prevention and Risk Reduction recommendations.

    The NCCN guideline is not reproduced in this policy. Providers may contact Health Services for a copy.

    Covered Lynch Syndrome Evaluation

    Evaluation for Lynch Syndrome

    Testing is covered when the requested evaluation meets the applicable NCCN criteria.

    Evaluation for Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer, must be performed under the applicable most recent NCCN guideline criteria.

    The policy does not reproduce the detailed NCCN criteria. Refer to the NCCN Genetic/Familial High-Risk Assessment: Colorectal guideline, including Detection, Prevention and Risk Reduction recommendations.

    Covered and Non-Covered Codes

    Covered CPT CodesCPTCovered
    81288MLH1 gene analysis; promoter methylation analysis
    81292MLH1 gene analysis; full sequence analysis
    81293MLH1 gene analysis; known familial variants
    81294MLH1 gene analysis; duplication/deletion variants
    81295MSH2 gene analysis; full sequence analysis
    81296MSH2 gene analysis; known familial variants
    Covered CPT CodesCPTCovered
    81297MSH2 gene analysis; duplication/deletion variants
    81298MSH6 gene analysis; full sequence analysis
    81299MSH6 gene analysis; known familial variants
    81300MSH6 gene analysis; duplication/deletion variants
    81317PMS2 gene analysis; full sequence analysis
    81318PMS2 gene analysis; known familial variants
    81319PMS2 gene analysis; duplication/deletion variants
    88341Immunohistochemistry or immunocytochemistry, per specimen; each additional single antibody stain procedure
    Covered CPT and Proprietary Laboratory CodesmixedCovered
    81301Microsatellite instability analysis of markers for mismatch repair deficiency, including comparison of neoplastic and normal tissue if performed
    81435Hereditary colon cancer disorders; genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants
    0238UOncology (Lynch syndrome), genomic DNA sequence analysis of MLH1, MSH2, MSH6, PMS2, and EPCAM, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
    0130UHereditary colon cancer disorders; targeted mRNA sequence analysis panel of APC, CDH1, CHEK2, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, and TP53
    Covered Additional Codes Requiring Prior AuthorizationmixedCovered
    0101UDescription not provided in policy text
    81403Description not provided in policy text
    81479Description not provided in policy text; listed as replacing deleted code 81436
    Not Covered Deleted or Replaced CodeCPTNot Covered
    81436Deleted effective 01/01/2025 and replaced by 81479

    Authorization and Documentation Requirements

    Prior Authorization

    Submit prior authorization through Pres Online

    Prior authorization is required for applicable Lynch syndrome testing. Submit the request through Pres Online.

    Billing Rule

    Codes requiring prior authorization

    The current annual review lists the following codes as requiring prior authorization:

    • 0101U
    • 0130U
    • 0238U
    • 81288
    • 81292

    Lynch Syndrome Overview

    Lynch syndrome, also known as hereditary nonpolyposis colorectal cancer, is an inherited cancer predisposition syndrome associated with mismatch repair genes. The policy addresses molecular evaluation involving MLH1, MSH2, EPCAM, MSH6, and PMS2, with gene-specific cancer-risk and surveillance/prevention considerations.

    Key Terms and Gene Categories

    Lynch syndrome
    DefinitionLynch syndrome is hereditary nonpolyposis colorectal cancer, an inherited cancer predisposition syndrome.
    Applicable terminologyThe policy refers to Lynch syndrome as hereditary nonpolyposis colorectal cancer.
    Coverage guidelinePresbyterian Health Plan follows the most recent NCCN Guideline for Lynch Syndrome and the Genetic/Familial High-Risk Assessment: Colorectal guideline section addressing Detection, Prevention and Risk Reduction.
    Gene-specific Lynch syndrome categories
    MLH1LS-B: gene-specific Lynch syndrome cancer risk and surveillance/prevention category.
    MSH2 and EPCAMLS-C: gene-specific Lynch syndrome cancer risk and surveillance/prevention category.

    Excluded or Removed Code

    CPT code 81436 is not covered under the current policy because it was deleted effective 01/01/2025 and removed from the policy. Code 81479 replaced 81436 in the current code list. Coverage is not guaranteed and must be determined under the member’s specific benefit plan and Schedule of Benefits.

    Policy Summary
    PayerPresbyterian Health Plan
    PolicyGenetic Testing for Lynch Syndrome
    Policy CodePolicy 7.5
    Change TypePolicy update
    Effective DateApr 18, 2024
    Last ReviewNov 19, 2025
    Next Review DateNot specified
    Key ActionPrior authorization is required; submit the request through Pres Online.
    SourceLink
    On This Page
    NCCN-Based Coverage CriteriaCovered Lynch Syndrome EvaluationCovered and Non-Covered CodesAuthorization and Documentation RequirementsLynch Syndrome OverviewKey Terms and Gene CategoriesExcluded or Removed Code
  1. 81293
  2. 81294
  3. 81295
  4. 81296
  5. 81297
  6. 81298
  7. 81299
  8. 81300
  9. 81301
  10. 81317
  11. 81318
  12. 81319
  13. 81403
  14. 81435
  15. 81479
  16. Documentation Required

    Maintain supporting guideline documentation

    Providers are expected to maintain or have access to the applicable source guideline documentation and provide supporting documentation when requested to support coverage. The applicable source guideline is the most recent NCCN guideline for Lynch syndrome.

    Note

    Verify the member benefit

    Verify the member’s specific benefit plan and Schedule of Benefits before providing testing. Benefits may differ by Presbyterian plan, and this testing may not be a benefit on all plans or may have broader or more limited benefits than those listed in the policy.

    Denial Risk

    NCCN criteria or prior authorization not met

    Coverage may not be authorized when the requested testing does not meet the most recent NCCN Lynch syndrome criteria or when required prior authorization is not obtained.

    MSH6LS-D: gene-specific Lynch syndrome cancer risk and surveillance/prevention category.
    PMS2LS-E: gene-specific Lynch syndrome cancer risk and surveillance/prevention category.